Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Lyn deficiency reduces GATA-1, EKLF and STAT5, and induces extramedullary stress erythropoiesis

Abstract

In vitro studies have implicated the Lyn tyrosine kinase in erythropoietin signaling. In this study, we show that J2E erythroid cells lacking Lyn have impaired signaling and reduced levels of transcription factors STAT5a, EKLF and GATA-1. Since mice lacking STAT5, EKLF or GATA-1 have red cell abnormalities, this study also examined the erythroid compartment of Lyn−/− mice. Significantly, STAT5, EKLF and GATA-1 levels were appreciably lower in Lyn−/− erythroblasts, and the phenotype of Lyn−/− animals was remarkably similar to GATA-1low animals. Although young adult Lyn-deficient mice had normal hematocrits, older mice developed anemia. Grossly enlarged erythroblasts and florid erythrophagocytosis were detected in the bone marrow of mice lacking Lyn. Markedly elevated erythroid progenitors and precursor levels were observed in the spleens, but not bone marrow, of Lyn−/− animals indicating that extramedullary erythropoiesis was occurring. These data indicate that Lyn−/− mice display extramedullary stress erythropoiesis to compensate for intrinsic and extrinsic erythroid defects.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Arai A, Kanda E, Nosaka Y, Miyasaka N and Miura O . (2001). J Biol Chem, 276, 33282–33290.

  • Bao HF, Jacobs-Helber SM, Lawson AE, Penta K, Wickrema A and Sawyer ST . (1999). Blood, 93, 3757–3773.

  • Bauer A, Tronche F, Wessely O, Kellendonk C, Reichardt HM, Steinlein P, Schutz G and Beug H . (1999). Genes Dev., 13, 2996–3002.

  • Brunati AM, Bordin L, Clari G, James P, Quadroni M, Baritono E, Pinna LA and Donella-Deana A . (2000). Blood, 96, 1550–1557.

  • Busfield SJ and Klinken SP . (1992). Blood, 80, 412–419.

  • Carroll MP, Spivak JL, McMahon M, Weich N, Rapp UR and May WS . (1991). J. Biol. Chem., 266, 14964–14969.

  • Chan VW, Meng F, Soriano P, DeFranco AL and Lowell CA . (1997). Immunity, 7, 69–81.

  • Chin H, Arai A, Wakao H, Kamiyama R, Miyasaka N and Miura O . (1998). Blood, 91, 3734–3745.

  • Coghill E, Eccleston S, Fox V, Cerruti L, Brown C, Cunningham J, Jane S and Perkins A . (2001). Blood, 97, 1861–1868.

  • Corey SJ and Anderson SM . (1999). Blood, 93, 1–14.

  • Damen JE, Mui AL-F, Puil L, Pawson T and Krystal G . (1993). Blood, 81, 3204–3210.

  • Damen JE, Wakao H, Miyajima A, Krosl J, Humphries RK, Cutler RL and Krystal G . (1995). EMBO J., 14, 5557–5568.

  • Gobert S, Chretien S, Gouileux F, Muller O, Pallard C, Dusanter-Fourt I, Groner B, Lacombe C, Gisselbrecht S and Mayeux P . (1996). EMBO J, 15, 2434–2441.

  • Gouilleux F, Pollard C, Dusanter-Fourt I, Wakao H, Haldosen L-A, Norstedt G, Levy D and Groner B . (1995). EMBO J., 14, 2005–2013.

  • Gregory RC, Jiang N, Todokoro K, Crouse J, Pacifici RE and Wojchowski DM . (1998). Blood, 92, 1104–1118.

  • Harashima A, Suzuki M, Okochi A, Yamamoto M, Matsuo Y, Motoda R, Yoshioka T and Orita K . (2002). Blood, 100, 4440–4445.

  • Harder KW, Parsons LM, Armes J, Evans N, Kountouri N, Clark R, Quilici C, Grail D, Hodgson GS, Dunn AR and Hibbs ML . (2001). Immunity, 15, 603–615.

  • Heyworth C, Pearson S, May G and Enver T . (2002). EMBO J., 21, 3770–3781.

  • Hibbs ML, Tarlinton DM, Armes J, Grail D, Hodgson G, Maglitto R, Stacker SA and Dunn AR . (1995). Cell, 83, 301–311.

  • Ingley E, Chappell D, Poon SY, Sarna MK, Beaumont JG, Williams JH, Stillitano JP, Tsai S, Leedman PJ, Tilbrook PA and Klinken SP . (2001). J. Biol. Chem., 276, 43428–43434.

  • Ingley E, Sarna MK, Beaumont JG, Tilbrook PA, Tsai S, Takemoto Y, Williams JH and Klinken SP . (2000). J. Biol. Chem., 275, 7887–7893.

  • Iwatsuki K, Endo T, Misawa H, Yokouchi M, Matsumoto A, Ohtsubo M, Mori KJ and Yoshimura A . (1997). J. Biol. Chem., 272, 8149–8152.

  • Kirito K, Uchida M, Takatoku M, Nakajima K, Hirano T, Miura Y and Komatsu N . (1998). Blood, 92, 462–471.

  • Klingmuller U, Bergelson S, Hsiao JG and Lodish HF . (1996). Proc. Natl. Acad. Sci. USA, 93, 8324–8328.

  • Klinken SP, Holmes K, Fredrickson TN, Erner SM and Morse HC . (1987). J. Immunol., 139, 3091–3098.

  • Klinken SP and Nicola NA . (1990). Leukemia, 4, 24–28.

  • Klinken SP, Nicola NA and Johnson GR . (1988). Proc. Natl. Acad. Sci. USA, 85, 8506–8510.

  • Krystal G . (1983). Exp. Hematol., 11, 649–660.

  • Kubota Y, Tanaka T, Kitanaka A, Ohnishi H, Okutani Y, Waki M, Ishida T and Kamano H . (2001). EMBO J., 20, 5666–5677.

  • Kulessa H, Frampton J and Graf T . (1995). Gene Dev., 9, 1250–1262.

  • Lecoq-Lafon C, Verdier F, Fichelson S, Chretien S, Gisselbrecht S, Lacombe C and Mayeux P . (1999). Blood, 93, 2578–2585.

  • McDevitt MA, Shivdasani RA, Fujiwara Y, Yang H and Orkin SH . (1997). Proc. Natl. Acad. Sci. USA, 94, 6781–6785.

  • McLeod DL, Shreeve MM and Axelrad AA . (1974). Blood, 44, 5176–5534.

  • Miller IJ and Bieker JJ . (1993). Mol. Cell. Biol., 13, 2776–2786.

  • Neubauer H, Cumano A, Muller M, Wu H, Huffstadt U and Pfeffer K . (1998). Cell, 93, 397–409.

  • Nishizumi H, Taniuchi I, Yamanashi Y, Kitamura D, Ilic D, Mori S, Watanabe T and Yamamoto T . (1995). Immunity, 3, 549–560.

  • Nuez B, Michalovich D, Bygrave A, Ploemacher R and Grosveld F . (1995). Nature, 375, 316–318.

  • Oda A, Sawada K, Druker BJ, Ozaki K, Takano H, Koizumi K, Fukada Y, Handa M, Koike T and Ikeda Y . (1998). Blood, 92, 443–451.

  • Ohashi T, Masuda M and Ruscetti SK . (1995). Blood, 85, 1454–1462.

  • Okutani Y, Kitanaka A, Tanaka T, Kamano H, Ohnishi H, Kubota Y, Ishida T and Takahara J . (2001). Oncogene, 20, 6643–6650.

  • Parganas E, Wang D, Stravopodis D, Topham DJ, Marine JC, Teglund S, Vanin EF, Bodner S, Colamonici OR, van Deursen JM, Grosveld G and Ihle JN . (1998). Cell, 93, 385–395.

  • Penta K and Sawyer ST . (1995). J. Biol. Chem., 270, 31282–31287.

  • Perkins AC, Sharpe AH and Orkin SH . (1995). Nature, 375, 318–322.

  • Pevny L, Simon MC, Robertson E, Klein WH, Tsai SF, D'Agati V, Orkin SH and Costantini F . (1991). Nature, 349, 257–260.

  • Ramsay RG, Ishii S and Gonda TJ . (1992). J. Biol. Chem., 267, 5656–5662.

  • Rylski M, Welch JJ, Chen YY, Letting DL, Diehl JA, Chodosh LA, Blobel GA and Weiss MJ . (2003). Mol. Cell. Biol., 23, 5031–5042.

  • Sarna MK, Ingley E, Busfield SJ, Cull VS, Lepere W, McCarthy DJ, Wright MJ, Palmer GA, Chappell D, Sayer MS, Alexander WS, Hilton DJ, Starr R, Watowich SS, Bittorf T, Klinken SP and Tilbrook PA . (2003). Oncogene, 22, 3221–3230.

  • Satterthwaite AB, Lowell CA, Khan WN, Sideras P, Alt FW and Witte ON . (1998). J. Exp. Med., 188, 833–844.

  • Socolovsky M, Fallon AE, Wang S, Brugnara C and Lodish HF . (1999). Cell, 98, 181–191.

  • Socolovsky M, Nam H, Fleming MD, Haase VH, Brugnara C and Lodish HF . (2001). Blood, 98, 3261–3273.

  • Spadaccini A, Tilbrook PA, Sarna MK, Crossley M, Bieker JJ and Klinken SP . (1998). J. Biol. Chem., 273, 23793–23798.

  • Teglund S, McKay C, Schuetz E, van Deursen JM, Stravopodis D, Wang D, Brown M, Bodner S, Grosveld G and Ihle JN . (1998). Cell, 93, 841–850.

  • Tilbrook PA, Bittorf T, Busfield SJ, Chappell D and Klinken SP . (1996a). J. Biol. Chem., 271, 3453–3459.

  • Tilbrook PA, Bittorf T, Callus B, Busfield SJ, Ingley E and Klinken SP . (1996b). Cell Growth Differ., 28, 175–181.

  • Tilbrook PA, Ingley E, Williams JH, Hibbs ML and Klinken SP . (1997). EMBO J., 16, 1610–1619.

  • Tilbrook PA, Palmer GA, Bittorf T, McCarthy DJ, Wright MJ, Sarna MK, Linnekin D, Cull VS, Williams JH, Ingley E, Schneider-Mergener J, Krystal G and Klinken SP . (2001). Cancer Res., 61, 2453–2458.

  • Tsai S, Martin DIK, Zon LI, D'Andrea AD, Wong GG and Orkin SH . (1989). Nature, 339, 446–451.

  • Vannucchi AM, Bianchi L, Cellai C, Paoletti F, Carrai V, Calzolari A, Centurione L, Lorenzini R, Carta C, Alfani E, Sanchez M, Migliaccio G and Migliaccio AR . (2001). Blood, 97, 3040–3050.

  • Wakao H, Harada N, Kitamura T, Mui AL and Miyajima A . (1995). EMBO J., 14, 2527–2535.

  • Weiss MJ, Keller G and Orkin SH . (1994). Genes Dev., 8, 1184–1197.

  • Whyatt D, Lindeboom F, Karis A, Ferreira R, Milot E, Hendriks R, de Bruijn M, Langeveld A, Gribnau J, Grosveld F and Philipsen S . (2000). Nature, 406, 519–524.

  • Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O and Ihle JN . (1993). Cell, 74, 227–236.

  • Wu H, Lui X, Jaenisch R and Lodish HF . (1995). Cell, 83, 59–67.

  • Yamaguchi Y, Zon LI, Ackerman SJ, Yamamoto M and Suda T . (1998). Blood, 91, 450–457.

Download references

Acknowledgements

We thank Dr Margaret Hibbs for making the Lyn−/− mice available and Shane Meakins for excellent technical assistance. This work was supported by grants from National Health and Medical Research Council (Grant 139008, 303101), the Cancer Foundation of Western Australia and the Medical Research Foundation of Royal Perth Hospital.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S Peter Klinken.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ingley, E., McCarthy, D., Pore, J. et al. Lyn deficiency reduces GATA-1, EKLF and STAT5, and induces extramedullary stress erythropoiesis. Oncogene 24, 336–343 (2005). https://doi.org/10.1038/sj.onc.1208199

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208199

Keywords

This article is cited by

Search

Quick links